179 related articles for article (PubMed ID: 22094332)
1. Potential role of insulin signaling on vascular smooth muscle cell migration, proliferation, and inflammation pathways.
Cersosimo E; Xu X; Musi N
Am J Physiol Cell Physiol; 2012 Feb; 302(4):C652-7. PubMed ID: 22094332
[TBL] [Abstract][Full Text] [Related]
2. Insulin regulation of proliferation involves activation of AKT and ERK 1/2 signaling pathways in vascular smooth muscle cells.
Isenovic ER; Fretaud M; Koricanac G; Sudar E; Velebit J; Dobutovic B; Marche P
Exp Clin Endocrinol Diabetes; 2009 May; 117(5):214-9. PubMed ID: 19235132
[TBL] [Abstract][Full Text] [Related]
3. Pioglitazone, a PPARγ agonist, attenuates PDGF-induced vascular smooth muscle cell proliferation through AMPK-dependent and AMPK-independent inhibition of mTOR/p70S6K and ERK signaling.
Osman I; Segar L
Biochem Pharmacol; 2016 Feb; 101():54-70. PubMed ID: 26643070
[TBL] [Abstract][Full Text] [Related]
4. Signal transduction of betacellulin in growth and migration of vascular smooth muscle cells.
Mifune M; Ohtsu H; Suzuki H; Frank GD; Inagami T; Utsunomiya H; Dempsey PJ; Eguchi S
Am J Physiol Cell Physiol; 2004 Sep; 287(3):C807-13. PubMed ID: 15163624
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory and anti-proliferative action of adiponectin mediated by insulin signaling cascade in human vascular smooth muscle cells.
Cersosimo E; Xu X; Terasawa T; Dong LQ
Mol Biol Rep; 2020 Sep; 47(9):6561-6572. PubMed ID: 32789574
[TBL] [Abstract][Full Text] [Related]
6. Role of PI3K/AKT, cPLA2 and ERK1/2 signaling pathways in insulin regulation of vascular smooth muscle cells proliferation.
Isenović ER; Kedees MH; Tepavcević S; Milosavljević T; Korićanac G; Trpković A; Marche P
Cardiovasc Hematol Disord Drug Targets; 2009 Sep; 9(3):172-80. PubMed ID: 19534657
[TBL] [Abstract][Full Text] [Related]
7. Klotho Inhibits Proliferation and Migration of Angiotensin II-Induced Vascular Smooth Muscle Cells (VSMCs) by Modulating NF-κB p65, Akt, and Extracellular Signal Regulated Kinase (ERK) Signaling Activities.
Yu S; Chen Y; Chen S; Ye N; Li Y; Sun Y
Med Sci Monit; 2018 Jul; 24():4851-4860. PubMed ID: 30004089
[TBL] [Abstract][Full Text] [Related]
8. Troglitazone inhibits mitogenic signaling by insulin in vascular smooth muscle cells.
Goetze S; Kim S; Xi XP; Graf K; Yang DC; Fleck E; Meehan WP; Hsueh WA; Law RE
J Cardiovasc Pharmacol; 2000 May; 35(5):749-57. PubMed ID: 10813377
[TBL] [Abstract][Full Text] [Related]
9. High fructose-mediated attenuation of insulin receptor signaling does not affect PDGF-induced proliferative signaling in vascular smooth muscle cells.
Osman I; Poulose N; Ganapathy V; Segar L
Eur J Pharmacol; 2016 Nov; 791():703-710. PubMed ID: 27729247
[TBL] [Abstract][Full Text] [Related]
10. Cardamonin inhibits angiotensin II-induced vascular smooth muscle cell proliferation and migration by downregulating p38 MAPK, Akt, and ERK phosphorylation.
Shen YJ; Zhu XX; Yang X; Jin B; Lu JJ; Ding B; Ding ZS; Chen SH
J Nat Med; 2014 Jul; 68(3):623-9. PubMed ID: 24595849
[TBL] [Abstract][Full Text] [Related]
11. Liraglutide attenuates high glucose-induced abnormal cell migration, proliferation, and apoptosis of vascular smooth muscle cells by activating the GLP-1 receptor, and inhibiting ERK1/2 and PI3K/Akt signaling pathways.
Shi L; Ji Y; Jiang X; Zhou L; Xu Y; Li Y; Jiang W; Meng P; Liu X
Cardiovasc Diabetol; 2015 Feb; 14():18. PubMed ID: 25855361
[TBL] [Abstract][Full Text] [Related]
12. The inhibitory effect of dexamethasone on platelet-derived growth factor-induced vascular smooth muscle cell migration through up-regulating PGC-1α expression.
Xu W; Guo T; Zhang Y; Jiang X; Zhang Y; Zen K; Yu B; Zhang CY
Exp Cell Res; 2011 May; 317(8):1083-92. PubMed ID: 20955697
[TBL] [Abstract][Full Text] [Related]
13. Pioglitazone inhibits homocysteine-induced migration of vascular smooth muscle cells through a peroxisome proliferator-activated receptor gamma-independent mechanism.
Li L; Gao PJ; Xi R; Wu CF; Zhu DL; Yan J; Lu GP
Clin Exp Pharmacol Physiol; 2008 Dec; 35(12):1471-6. PubMed ID: 18759864
[TBL] [Abstract][Full Text] [Related]
14. Urokinase-induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor.
Nicholl SM; Roztocil E; Davies MG
J Vasc Surg; 2005 Apr; 41(4):672-81. PubMed ID: 15874933
[TBL] [Abstract][Full Text] [Related]
15. Ketamine, a Clinically Used Anesthetic, Inhibits Vascular Smooth Muscle Cell Proliferation via PP2A-Activated PI3K/Akt/ERK Inhibition.
Chang Y; Li JY; Jayakumar T; Hung SH; Lee WC; Manubolu M; Sheu JR; Hsu MJ
Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29186909
[TBL] [Abstract][Full Text] [Related]
16. ERK and Akt signaling pathways are involved in advanced glycation end product-induced autophagy in rat vascular smooth muscle cells.
Hu P; Lai D; Lu P; Gao J; He H
Int J Mol Med; 2012 Apr; 29(4):613-8. PubMed ID: 22293957
[TBL] [Abstract][Full Text] [Related]
17. miR-18a-5p Promotes Proliferation and Migration of Vascular Smooth Muscle Cells by Activating the AKT/Extracellular Regulated Protein Kinases (ERK) Signaling Pathway.
Zhang Y; Chen X
Med Sci Monit; 2020 May; 26():e924625. PubMed ID: 32458821
[TBL] [Abstract][Full Text] [Related]
18. Apamin inhibits PDGF-BB-induced vascular smooth muscle cell proliferation and migration through suppressions of activated Akt and Erk signaling pathway.
Kim JY; Kim KH; Lee WR; An HJ; Lee SJ; Han SM; Lee KG; Park YY; Kim KS; Lee YS; Park KK
Vascul Pharmacol; 2015 Jul; 70():8-14. PubMed ID: 25737404
[TBL] [Abstract][Full Text] [Related]
19. Sphingosine 1-phosphate induces EGFR expression via Akt/NF-kappaB and ERK/AP-1 pathways in rat vascular smooth muscle cells.
Hsieh HL; Sun CC; Wu CB; Wu CY; Tung WH; Wang HH; Yang CM
J Cell Biochem; 2008 Apr; 103(6):1732-46. PubMed ID: 17902169
[TBL] [Abstract][Full Text] [Related]
20. The inhibition of insulin-stimulated proliferation of vascular smooth muscle cells by rosiglitazone is mediated by the Akt-mTOR-P70S6K pathway.
Park S; Lim S; Chang W; Song H; Lee S; Song BW; Kim HJ; Cha MJ; Choi E; Jang Y; Chung N; Cho SY; Hwang KC
Yonsei Med J; 2008 Aug; 49(4):592-600. PubMed ID: 18729301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
